{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:31Z","timestamp":1790870491509,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["20K20769"],"award-info":[{"award-number":["20K20769"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["20H01546"],"award-info":[{"award-number":["20H01546"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["21H00739"],"award-info":[{"award-number":["21H00739"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.drudis.2024.103911","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T11:34:09Z","timestamp":1706873649000},"page":"103911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Kenta","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongjoo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sengoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-2034","authenticated-orcid":false,"given":"Kota","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.103911_b0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.drudis.2024.103911_b0010","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2024.103911_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2024.103911_b0020","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231209839","article-title":"Novel anti-amyloid-beta (A\u03b2) monoclonal antibody lecanemab for Alzheimer\u2019s disease: A systematic review","volume":"37","author":"Chowdhury","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.drudis.2024.103911_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s disease neuroimaging initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2024.103911_b0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.drudis.2024.103911_b0035","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419888819","article-title":"Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer\u2019s disease","volume":"12","author":"Mil\u00e0-Alom\u00e0","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.drudis.2024.103911_b0040","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1038\/s41598-021-89004-x","article-title":"Highly specific and ultrasensitive plasma test detects Abeta(1\u201342) and Abeta(1\u201340) in Alzheimer\u2019s disease","volume":"11","author":"Thijssen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.103911_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103677","article-title":"Global biomarker trends in Alzheimer's research: A bibliometric analysis","volume":"28","author":"Noda","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.103911_b0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma biomarkers of Alzheimer\u2019s disease: a review of available assays, recent developments, and implications for clinical practice","volume":"71","author":"Pais","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.drudis.2024.103911_b0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drudis.2019.11.009","article-title":"Holistic cost-effectiveness analysis of anticancer drug regimens in Japan","volume":"25","author":"Teramae","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2024.103911_b0060","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40258-018-0395-5","article-title":"Consequences of biomarker analysis on the cost-effectiveness of cetuximab in combination with FOLFIRI as a first-line treatment of metastatic colorectal cancer: Personalised medicine at work","volume":"16","author":"Harty","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.drudis.2024.103911_b0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00406-022-01439-z","article-title":"Cost-effectiveness of Alzheimer\u2019s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis","volume":"273","author":"Contador","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.drudis.2024.103911_b0070","doi-asserted-by":"crossref","first-page":"e1682","DOI":"10.1212\/WNL.0000000000005476","article-title":"Prevalence of preclinical Alzheimer disease: comparison of current classification systems","volume":"90","author":"Kern","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2024.103911_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-017-0260-z","article-title":"Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database","volume":"9","author":"Ben Bouall\u00e8gue","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.drudis.2024.103911_b0080","doi-asserted-by":"crossref","first-page":"fcab008","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of \u03b2-amyloid positivity in Alzheimer\u2019s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.drudis.2024.103911_b0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40120-022-00350-y","article-title":"Long-term health outcomes of lecanemab in patients with early Alzheimer\u2019s disease using simulation modeling","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.drudis.2024.103911_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14283\/jpad.2021.70","article-title":"Blood derived amyloid biomarkers for Alzheimer\u2019s disease prevention","volume":"9","author":"Udeh-Momoh","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.drudis.2024.103911_b0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/alz.13449","article-title":"The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer\u2019s disease treatment: a review of ADNI studies from 2021 to 2022","volume":"20","author":"Veitch","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2024.103911_b0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40120-023-00460-1","article-title":"Estimated societal value of lecanemab in patients with early Alzheimer\u2019s disease using simulation modeling","volume":"12","author":"Tahami Monfared","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.drudis.2024.103911_b0105","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/annonc\/mdx305","article-title":"The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC","volume":"28","author":"Aguiar","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.drudis.2024.103911_b0110","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","author":"Rissman","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2024.103911_b0115","first-page":"111","article-title":"Consensus guidelines for lumbar puncture in patients with neurological diseases","volume":"8","author":"Engelborghs","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2024.103911_b0120","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119871066","article-title":"Public knowledge and attitude toward lumbar puncture among adults in Riyadh, Saudi Arabia: a cross-sectional study","volume":"7","author":"Aldayel","year":"2019","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.drudis.2024.103911_b0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2024.103911_b0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3988\/jcn.2022.18.4.401","article-title":"Promising blood biomarkers for clinical use in Alzheimer\u2019s disease: a focused update","volume":"18","author":"Park","year":"2022","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.drudis.2024.103911_b0135","doi-asserted-by":"crossref","first-page":"1119070","DOI":"10.3389\/fnagi.2023.1119070","article-title":"Association of APOE \u03b54\/\u03b54 with fluid biomarkers in patients from the PUMCH dementia cohort","volume":"15","author":"Shang","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2024.103911_b0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2217\/cer.15.41","article-title":"The importance of test accuracy in economic evaluations of companion diagnostics","volume":"4","author":"San Miguel","year":"2015","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.drudis.2024.103911_b0145","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer\u2019s Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:09:04Z","timestamp":1761224944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1359644624000369"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103911","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103911"}}